Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

Merck Sharp & Dohme LLC · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
carcinomarenal-cell-carcinoma
renal cell carcinoma, carcinoma, renal cell, belzutifan, zanzalintinib, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 859630
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.